JW Shinyak Corporation (KOSDAQ: 067290)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,523.00
-55.00 (-3.49%)
Jan 20, 2025, 9:00 AM KST
-28.93%
Market Cap 81.76B
Revenue (ttm) 101.41B
Net Income (ttm) 7.35B
Shares Out 53.23M
EPS (ttm) 137.70
PE Ratio 11.15
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 113,914
Average Volume 112,305
Open 1,564.00
Previous Close 1,578.00
Day's Range 1,512.00 - 1,564.00
52-Week Range 1,220.00 - 2,190.48
Beta 0.76
RSI 49.09
Earnings Date Mar 19, 2025

About JW Shinyak

JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheum... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1981
Employees 197
Stock Exchange KOSDAQ
Ticker Symbol 067290
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.